the Fetal Epicardial Thickness in Obese Pregnant Women (EFT)
EFT
The Effect of Myocardial Performance Index and Fetal Epicardial Thickness on Perinatal Outcomes in Obese Pregnant Women
1 other identifier
interventional
120
1 country
1
Brief Summary
the effects of fetal EFT on fetal cardiac function and fetal and maternal outcomes were investigated in obese pregnant women compared with normal-weight pregnant women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedFirst Submitted
Initial submission to the registry
May 27, 2023
CompletedFirst Posted
Study publicly available on registry
July 17, 2023
CompletedJuly 17, 2023
July 1, 2023
7 months
May 27, 2023
July 14, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
birth weight (gram)
fetal outcome
birth 1 week
stillbirth rate (%)
fetal outcome
birth 1 week
NICU admission
fetal outcome
6 months
Study Arms (2)
myocardial performance and epicard thickness in obese pregnant women
ACTIVE COMPARATORobese pregnant versus normal-weight pregnant women were evaluated for MPI and fetal epicardial thickness
obese pregnant
ACTIVE COMPARATORobese pregnant versus normal-weight pregnant women were evaluated for MPI and fetal epicardial thickness
Interventions
Doppler study was performed in all cases. perinatal outcomes were evaluated.
Eligibility Criteria
You may qualify if:
- Obese pregnant women
- normal-weight pregnant women
- gestational week
You may not qualify if:
- Twin pregnancies, structural and chromosomal abnormalities, fetal rhesus isoimmunization, fetal growth restriction, cases with infections detected by maternal serological tests, pregestational or gestational diabetes (All patients underwent a 75-gram glucose load test at 24 weeks to rule out diabetes), preeclampsia, premature rupture of membranes were excluded from the study -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Necmettin Erbakan University
Konya, 42140, Turkey (Türkiye)
Related Publications (1)
Dogru S, Akkus F, Metin US, Acar A. Fetal Epicardial Fat Thickness in Obese Pregnant Women: Its Effect on Fetal Cardiac Function and Neonatal Outcomes. Z Geburtshilfe Neonatol. 2024 Oct;228(5):439-445. doi: 10.1055/a-2267-5478. Epub 2024 Mar 19.
PMID: 38503305DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
şükran DR doğru, md
NECMETTİN ERBAKAN UNIVERCITY
- PRINCIPAL INVESTIGATOR
fatih dr akkuş, md
NECMETTİN ERBAKAN UNIVERCITY
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- obese and non obese pregnant women
- Purpose
- SCREENING
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- medical director
Study Record Dates
First Submitted
May 27, 2023
First Posted
July 17, 2023
Study Start
October 1, 2022
Primary Completion
April 30, 2023
Study Completion
April 30, 2023
Last Updated
July 17, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- 2 MONTHS
- Access Criteria
- VİA MAİL ADDRESS
provided by the responsible researgher if requested